202 related articles for article (PubMed ID: 36972299)
21. A single-field integrated boost treatment planning technique for spot scanning proton therapy.
Zhu XR; Poenisch F; Li H; Zhang X; Sahoo N; Wu RY; Li X; Lee AK; Chang EL; Choi S; Pugh T; Frank SJ; Gillin MT; Mahajan A; Grosshans DR
Radiat Oncol; 2014 Sep; 9():202. PubMed ID: 25212571
[TBL] [Abstract][Full Text] [Related]
22. A new treatment planning approach accounting for prompt gamma range verification and interfractional anatomical changes.
Tian L; Landry G; Dedes G; Pinto M; Kamp F; Belka C; Parodi K
Phys Med Biol; 2020 Apr; 65(9):095005. PubMed ID: 32135530
[TBL] [Abstract][Full Text] [Related]
23. Dosimetric study of uniform scanning proton therapy planning for prostate cancer patients with a metal hip prosthesis, and comparison with volumetric-modulated arc therapy.
Rana S; Cheng C; Zheng Y; Hsi W; Zeidan O; Schreuder N; Vargas C; Larson G
J Appl Clin Med Phys; 2014 May; 15(3):4611. PubMed ID: 24892333
[TBL] [Abstract][Full Text] [Related]
24. Validation of linear energy transfer computed in a Monte Carlo dose engine of a commercial treatment planning system.
Wagenaar D; Tran LT; Meijers A; Marmitt GG; Souris K; Bolst D; James B; Biasi G; Povoli M; Kok A; Traneus E; van Goethem MJ; Langendijk JA; Rosenfeld AB; Both S
Phys Med Biol; 2020 Jan; 65(2):025006. PubMed ID: 31801119
[TBL] [Abstract][Full Text] [Related]
25. Towards FLASH proton therapy: the impact of treatment planning and machine characteristics on achievable dose rates.
van de Water S; Safai S; Schippers JM; Weber DC; Lomax AJ
Acta Oncol; 2019 Oct; 58(10):1463-1469. PubMed ID: 31241377
[No Abstract] [Full Text] [Related]
26. Measurement-based range evaluation for quality assurance of CBCT-based dose calculations in adaptive proton therapy.
Neppl S; Kurz C; Köpl D; Yohannes I; Schneider M; Bondesson D; Rabe M; Belka C; Dietrich O; Landry G; Parodi K; Kamp F
Med Phys; 2021 Aug; 48(8):4148-4159. PubMed ID: 34032301
[TBL] [Abstract][Full Text] [Related]
27. Maximizing the biological effect of proton dose delivered with scanned beams via inhomogeneous daily dose distributions.
Zeng C; Giantsoudi D; Grassberger C; Goldberg S; Niemierko A; Paganetti H; Efstathiou JA; Trofimov A
Med Phys; 2013 May; 40(5):051708. PubMed ID: 23635256
[TBL] [Abstract][Full Text] [Related]
28. Toward a new treatment planning approach accounting for in vivo proton range verification.
Tian L; Landry G; Dedes G; Kamp F; Pinto M; Niepel K; Belka C; Parodi K
Phys Med Biol; 2018 Oct; 63(21):215025. PubMed ID: 30375361
[TBL] [Abstract][Full Text] [Related]
29. Accurate proton treatment planning for pencil beam crossing titanium fixation implants.
Righetto R; Clemens LP; Lorentini S; Fracchiolla F; Algranati C; Tommasino F; Dionisi F; Cianchetti M; Schwarz M; Farace P
Phys Med; 2020 Feb; 70():28-38. PubMed ID: 31954210
[TBL] [Abstract][Full Text] [Related]
30. A Universal Range Shifter and Range Compensator Can Enable Proton Pencil Beam Scanning Single-Energy Bragg Peak FLASH-RT Treatment Using Current Commercially Available Proton Systems.
Kang M; Wei S; Choi JI; Lin H; Simone CB
Int J Radiat Oncol Biol Phys; 2022 May; 113(1):203-213. PubMed ID: 35101597
[TBL] [Abstract][Full Text] [Related]
31. Robust beam orientation optimization for intensity-modulated proton therapy.
Gu W; Neph R; Ruan D; Zou W; Dong L; Sheng K
Med Phys; 2019 Aug; 46(8):3356-3370. PubMed ID: 31169917
[TBL] [Abstract][Full Text] [Related]
32. Exploratory Study of 4D versus 3D Robust Optimization in Intensity Modulated Proton Therapy for Lung Cancer.
Liu W; Schild SE; Chang JY; Liao Z; Chang YH; Wen Z; Shen J; Stoker JB; Ding X; Hu Y; Sahoo N; Herman MG; Vargas C; Keole S; Wong W; Bues M
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):523-533. PubMed ID: 26725727
[TBL] [Abstract][Full Text] [Related]
33. Dosimetric advantages of IMPT over IMRT for laser-accelerated proton beams.
Luo W; Li J; Fourkal E; Fan J; Xu X; Chen Z; Jin L; Price R; Ma CM
Phys Med Biol; 2008 Dec; 53(24):7151-66. PubMed ID: 19033641
[TBL] [Abstract][Full Text] [Related]
34. Uncertainty reduction in intensity modulated proton therapy by inverse Monte Carlo treatment planning.
Morávek Z; Rickhey M; Hartmann M; Bogner L
Phys Med Biol; 2009 Aug; 54(15):4803-19. PubMed ID: 19622848
[TBL] [Abstract][Full Text] [Related]
35. Treatment planning comparison of IMPT, VMAT and 4π radiotherapy for prostate cases.
Tran A; Zhang J; Woods K; Yu V; Nguyen D; Gustafson G; Rosen L; Sheng K
Radiat Oncol; 2017 Jan; 12(1):10. PubMed ID: 28077128
[TBL] [Abstract][Full Text] [Related]
36. Intensity modulated proton arc therapy via geometry-based energy selection for ependymoma.
Cao W; Li Y; Zhang X; Poenisch F; Yepes P; Sahoo N; Grosshans D; McGovern S; Gunn GB; Frank SJ; Zhu XR
J Appl Clin Med Phys; 2023 Jul; 24(7):e13954. PubMed ID: 36913484
[TBL] [Abstract][Full Text] [Related]
37. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
[TBL] [Abstract][Full Text] [Related]
38. The use of non-standard CT conversion ramps for Monte Carlo verification of 6 MV prostate IMRT plans.
Zarza-Moreno M; Cardoso I; Teixeira N; Jesus AP; Mora G
Phys Med; 2013 Jun; 29(4):357-67. PubMed ID: 22677401
[TBL] [Abstract][Full Text] [Related]
39. Dose uncertainties in IMPT for oropharyngeal cancer in the presence of anatomical, range, and setup errors.
Kraan AC; van de Water S; Teguh DN; Al-Mamgani A; Madden T; Kooy HM; Heijmen BJ; Hoogeman MS
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):888-96. PubMed ID: 24351409
[TBL] [Abstract][Full Text] [Related]
40. The energy margin strategy for reducing dose variation due to setup uncertainty in intensity modulated proton therapy (IMPT) delivered with distal edge tracking (DET).
Zhang M; Flynn RT; Mo X; Mackie TR
J Appl Clin Med Phys; 2012 Sep; 13(5):3863. PubMed ID: 22955652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
